ilaprazole: Clinical Trials

5 trials of ilaprazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Unknown 1
Phase 31Completed 1

Follow ilaprazole: new trials by email Literature Review of ilaprazole trials Research Report on ilaprazole

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
Ilaprazole, omeprazole - Peptic Ulcer Hemorrhage
Phase 2CompletedLivzon Pharmaceutical Group Inc.1802014-02-012017-12-06
Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients
10 mg ilaprazole, 15 mg ilaprazole, 40 mg esomeprazole - Gastroesophageal Reflux Disease
Phase 2UnknownLivzon Pharmaceutical Group Inc.3302010-05-012010-04-21
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients
5 mg ilaprazole, 10 mg ilaprazole, 10 mg Rabeprazole - Duodenal Ulcer
Phase 2 / Phase 3CompletedLivzon Pharmaceutical Group Inc.4082008-08-012016-07-28
Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis
Ilaprazole, Lansoprazole - Esophagitis
Phase 2CompletedTakeda8312007-05-012012-02-02
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)
5 mg ilaprazole, 10 mg ilaprazole, 20 mg ilaprazole - Duodenal Ulcer
Phase 2CompletedLivzon Pharmaceutical Group Inc.2352004-10-012009-08-06

Conditions studied

Duodenal Ulcer (2)  ·  Esophagitis (1)  ·  Gastroesophageal Reflux (1)  ·  Heartburn (1)  ·  Peptic Ulcer Hemorrhage (1)

Sponsors

Livzon Pharmaceutical Group Inc. (4)  ·  Takeda (1)

Countries

China (1)  ·  United States (1)

Top investigators

Liya Zhou, MD (1)  ·  S R Lin, M.D (1)  ·  Sanren Lin, MD (1)

Results publications

PMID 20679904, PMID 27605258, PMID 38910891